166 related articles for article (PubMed ID: 22481252)
41. Epidermal growth factor gene polymorphism 61A/G in patients with chronic liver disease for early detection of hepatocellular carcinoma: a pilot study.
Abbas E; Shaker O; Abd El Aziz G; Ramadan H; Esmat G
Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):458-63. PubMed ID: 22293333
[TBL] [Abstract][Full Text] [Related]
42. Effect of epidermal growth factor receptor gene polymorphisms on prognosis in glioma patients.
Li B; Zhao W; Li J; Yan M; Xie Z; Zhu Y; Chen C; Jin T
Oncotarget; 2016 Sep; 7(39):63054-63064. PubMed ID: 27437777
[TBL] [Abstract][Full Text] [Related]
43. Intranasal Perillyl Alcohol for Glioma Therapy: Molecular Mechanisms and Clinical Development.
Chen TC; da Fonseca CO; Schönthal AH
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30563210
[TBL] [Abstract][Full Text] [Related]
44. A functional +61G/A polymorphism in epidermal growth factor is associated with glioma risk among Asians.
Xu X; Xi L; Zeng J; Yao Q
PLoS One; 2012; 7(7):e41470. PubMed ID: 22829952
[TBL] [Abstract][Full Text] [Related]
45. Correlations of EGF G1380A, bFGF C754G and VEGF T460C polymorphisms with malignant melanoma susceptibility and prognosis: A case-control study.
Wang XH; Long ZW
Gene; 2017 Jun; 617():44-53. PubMed ID: 28219779
[TBL] [Abstract][Full Text] [Related]
46. Epidermal growth factor serum levels and the 61 G/A polymorphism in patients with acute pancreatitis.
Papachristou GI; Muddana V; Papachristou DJ; Stello K; Whitcomb DC
Dig Dis Sci; 2010 Sep; 55(9):2676-80. PubMed ID: 20127414
[TBL] [Abstract][Full Text] [Related]
47. Epidermal growth factor (EGF) A61G polymorphism and EGF gene expression in normal colon tissue from patients with colorectal cancer.
Spindler KL; Nielsen JN; Ornskov D; Brandslund I; Jakobsen A
Acta Oncol; 2007; 46(8):1113-7. PubMed ID: 17851837
[TBL] [Abstract][Full Text] [Related]
48. [Interaction analysis between epidermal growth factor and peroxidase proliferators activate receptor-α gene polymorphism and susceptibility to generalized aggressive periodontitis].
Wang XE; Meng HX; Lu RF; Feng XH; Xu L; Shi D
Zhonghua Kou Qiang Yi Xue Za Zhi; 2020 Jul; 55(7):482-487. PubMed ID: 32634887
[No Abstract] [Full Text] [Related]
49. Pre-diagnostic serum levels of EGFR and ErbB2 and genetic glioma risk variants: a nested case-control study.
Späth F; Andersson U; Dahlin AM; Langseth H; Hovig E; Johannesen TB; Grankvist K; Björkblom B; Wibom C; Melin B
Tumour Biol; 2016 Aug; 37(8):11065-72. PubMed ID: 26906551
[TBL] [Abstract][Full Text] [Related]
50. A single nucleotide polymorphism in the 5' untranslated region of the EGF gene is associated with occurrence and malignant progression of gastric cancer.
Hamai Y; Matsumura S; Matsusaki K; Kitadai Y; Yoshida K; Yamaguchi Y; Imai K; Nakachi K; Toge T; Yasui W
Pathobiology; 2005; 72(3):133-8. PubMed ID: 15860930
[TBL] [Abstract][Full Text] [Related]
51. Association of Epidermal Growth Factor 61A>G, Survivin -31G>C, and EFNA1 -1732G>A Polymorphisms with Susceptibility to Colorectal Cancer.
Asadian F; Ghadyani M; Antikchi MH; Dastgheib SA; Neamatzadeh H; Sheikhpour E; Khajehnoori S; Tabei SS
J Gastrointest Cancer; 2022 Mar; 53(1):78-83. PubMed ID: 33180239
[TBL] [Abstract][Full Text] [Related]
52. Association between polymorphisms of epidermal growth factor 61 and susceptibility of lung cancer: A meta-analysis.
Chen Q; Zheng Y; Wu B; Chen X; Ge P; Wang P
Medicine (Baltimore); 2020 Apr; 99(17):e19456. PubMed ID: 32332599
[TBL] [Abstract][Full Text] [Related]
53. Essential role of polymorphism of Gab1, EGFR, and EGF for the susceptibility of biliary tract cancer.
Meng LQ
Tumour Biol; 2014 Dec; 35(12):12497-508. PubMed ID: 25217982
[TBL] [Abstract][Full Text] [Related]
54. Carriage of the EGF rs4444903 A>G functional polymorphism associates with disease progression in chronic HBV infection.
Cmet S; Fabris C; Fattovich G; Falleti E; Bitetto D; Cussigh A; Fontanini E; Fornasiere E; Pirisi M; Toniutto P
Clin Exp Immunol; 2012 Feb; 167(2):296-302. PubMed ID: 22236006
[TBL] [Abstract][Full Text] [Related]
55. Analyses of EGF A61G Gene Variation and Serum EGF Level on Gastric Cancer Susceptibility and Clinicopathological Parameters.
Cacina C; Arikan S; Düzköylü Y; Doğan MB; Okay E; Turan S; Yaylim I; Isbir T
Anticancer Res; 2015 May; 35(5):2709-13. PubMed ID: 25964549
[TBL] [Abstract][Full Text] [Related]
56. EGF +61A/G polymorphism contributes to increased gastric cancer risk: evidence from a meta-analysis.
Peng Q; Li S; Qin X; Lao X; Chen Z; Zhang X; Chen J
Cancer Cell Int; 2014; 14():134. PubMed ID: 25729328
[TBL] [Abstract][Full Text] [Related]
57. Effects of the functional HOTAIR rs920778 and rs12826786 genetic variants in glioma susceptibility and patient prognosis.
Xavier-Magalhães A; Oliveira AI; de Castro JV; Pojo M; Gonçalves CS; Lourenço T; Viana-Pereira M; Costa S; Linhares P; Vaz R; Nabiço R; Amorim J; Pinto AA; Reis RM; Costa BM
J Neurooncol; 2017 Mar; 132(1):27-34. PubMed ID: 28083786
[TBL] [Abstract][Full Text] [Related]
58. Influence of apoptosis (BCL2, FAS), cell cycle (CCND1) and growth factor (EGF, EGFR) genetic polymorphisms on survival outcome: an exploratory study in squamous cell esophageal cancer.
Jain M; Kumar S; Upadhyay R; Lal P; Tiwari A; Ghoshal UC; Mittal B
Cancer Biol Ther; 2007 Oct; 6(10):1553-8. PubMed ID: 17912028
[TBL] [Abstract][Full Text] [Related]
59. Association of the epidermal growth factor gene +61A>G polymorphism with hepatocellular carcinoma in an Iranian population.
Gholizadeh M; Khosravi A; Torabian P; Gholipoor N; Mansour Samaei N
Gastroenterol Hepatol Bed Bench; 2017; 10(4):284-288. PubMed ID: 29379593
[TBL] [Abstract][Full Text] [Related]
60. Quantitative assessment of the effect of epidermal growth factor 61A/G polymorphism on the risk of hepatocellular carcinoma.
Shen XF; Zeng XT; Jian ZY; Zhou M; Zhou P; Zhang M
Oncol Lett; 2015 Nov; 10(5):3199-3205. PubMed ID: 26722312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
